Results 71 to 80 of about 5,906 (213)

Plasma copeptin level in type 2 diabetic patients and its role in diabetic nephropathy

open access: yesThe Egyptian Journal of Internal Medicine, 2023
Background Copeptin, the stable COOH-terminal portion of pre-provasopressin and a surrogate marker of vasopressin, was shown to be positively associated with the decline in kidney function in the general population.
Nevein Nabil El-Soudany   +3 more
doaj   +1 more source

Blood flow restriction: The acute effects of body tilting and reduced gravity analogues on limb occlusion pressure

open access: yesExperimental Physiology, Volume 111, Issue 9, Page 4103-4114, 1 September 2026.
Abstract Blood flow restriction (BFR) has been identified as a potential countermeasure to mitigate physiological deconditioning during spaceflight. Guidelines recommend that tourniquet pressure be prescribed relative to limb occlusion pressure (LOP); however, it is unclear whether body tilting or reduced gravity analogues influence LOP.
Patrick Swain, Nick Caplan, Luke Hughes
wiley   +1 more source

Copeptin in aneurysmal subarachnoid hemorrhage [PDF]

open access: yesCritical Care, 2012
Copeptin is a peptide derived from pre-provasospression along with arginine vasospressin. In the setting of aneurysmal subarachnoid hemorrhage (SAH), elevated serum copeptin levels correlate with vasospasm, inpatient mortality, mortality at 1 year, and poor functional outcome at 1 year.
openaire   +2 more sources

Copeptin as a predictive marker of incident heart failure

open access: yesESC Heart Failure, 2021
Aims Heart failure (HF) is a common disease with increasing prevalence and poor prognosis. The vasopressin (VP) marker copeptin predicts development of diabetes mellitus, diabetic heart disease, coronary artery disease, and premature mortality.
Fredrika Schill   +4 more
doaj   +1 more source

SGLT2 gene expression in thirst‐promoting NOS1 neurons and vasopressin‐synthesizing neurons in male rats

open access: yesPhysiological Reports, Volume 14, Issue 17, September 2026.
Abstract While sodium–glucose cotransporter 2 (SGLT2) inhibitors exert diuretic effects, they cause only mild changes in body fluid balance, partly through compensatory increases in water intake and vasopressin (AVP) secretion. However, whether SGLT2 inhibitors directly influence central pathways governing these fluid‐regulatory responses remains ...
Takahiro Masuda   +6 more
wiley   +1 more source

Copeptin in vasovagal syncope [PDF]

open access: yesEuropean Heart Journal, 2013
Purpose: The arginine-vasopressin (AVP) system is one of the main blood pressure regulating systems. Copeptin is a stable and sensitive surrogate marker for AVP release. Vasovagal syncope (VVS) is the most common type of syncope. The purpose of this study was to assess copeptin, as a marker of AVP system responsiveness, in patients (pts) with VVS ...
P. Flevari   +7 more
openaire   +1 more source

Copeptin: a biochemical predictor of metabolic syndrome in children and adolescents with obesity

open access: yesEgyptian Pediatric Association Gazette
Background Copeptin hormone is a stable arginine vasopressin biomarker. High concentrations of this peptide have been linked to obesity and metabolic syndrome.
Marwa Farouk Mira   +4 more
doaj   +1 more source

Concentrations of the stress hormone copeptin increase upon hypoglycaemia in patients with type 1 diabetes dependent of hypoglycaemia awareness.

open access: yesPLoS ONE, 2013
ObjectiveCopeptin, a marker for stress mirroring vasopressin concentrations, has been shown to increase upon insulin-induced hypoglycaemia in patients after transsphenoidal surgery of pituitary adenomas.
Eleonora Seelig   +4 more
doaj   +1 more source

Renal function interferes with copeptin in prediction of major adverse cardiac events in patients undergoing vascular surgery. [PDF]

open access: yesPLoS ONE, 2015
OBJECTIVE:Precise perioperative risk stratification is important in vascular surgery patients who are at high risk for major adverse cardiovascular events (MACE) peri- and postoperatively.
Claudia Schrimpf   +10 more
doaj   +1 more source

Diagnostic Value of Neurofilament Light Chain and Glial Fibrillary Acidic Protein in Differentiating Primary From Serious Secondary Headache

open access: yesEuropean Journal of Neurology, Volume 33, Issue 7, July 2026.
In patients presenting to the emergency department with acute non‐traumatic headache, serum GFAP and neurofilament light chain were higher in serious secondary headache than in primary headache. GFAP showed stronger diagnostic performance and remained independently associated with serious secondary headache after adjustment for clinical risk factors ...
Sara‐Jessica Camerin   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy